Free Trial
NASDAQ:RNTX

Rein Therapeutics (RNTX) Stock Price, News & Analysis

Rein Therapeutics logo
$1.11 -0.06 (-4.72%)
As of 08/1/2025 03:59 PM Eastern

About Rein Therapeutics Stock (NASDAQ:RNTX)

Key Stats

Today's Range
$1.11
$1.18
50-Day Range
$1.11
$2.05
52-Week Range
$1.05
$4.40
Volume
24,881 shs
Average Volume
46,174 shs
Market Capitalization
$25.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RNTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rein Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

RNTX Stock News Headlines

RNTX - Rein Therapeutics Inc Dividends - Morningstar
Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift
Trump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to unlock federal lands, oil reserves, and buried minerals... all for profit. Trump's team is already executing the orders... and Wall Street legend Whitney Tilson is stepping forward to show you how to position before the deadline.
RNTX Rein Therapeutics Inc.
See More Headlines

RNTX Stock Analysis - Frequently Asked Questions

Rein Therapeutics' stock was trading at $2.05 at the beginning of the year. Since then, RNTX stock has decreased by 45.9% and is now trading at $1.11.

Rein Therapeutics Inc. (NASDAQ:RNTX) announced its quarterly earnings results on Thursday, May, 15th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by $0.04.

Top institutional investors of Rein Therapeutics include University of Texas Texas AM Investment Management Co. (2.31%), Chicago Partners Investment Group LLC (0.19%), Exencial Wealth Advisors LLC (0.14%) and Blair William & Co. IL (0.11%).

Shares of RNTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
8/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RNTX
CIK
1420565
Web
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$62.88 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-86.07%
Return on Assets
-31.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.39
Quick Ratio
1.39

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.39 per share
Price / Cash Flow
2.84
Book Value
$0.43 per share
Price / Book
2.58

Miscellaneous

Outstanding Shares
22,154,000
Free Float
21,024,000
Market Cap
$24.59 million
Optionable
N/A
Beta
1.22
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:RNTX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners